|
|
|
|
LEADER |
00000cam a2200000Ma 4500 |
001 |
SCIDIR_ocn646758023 |
003 |
OCoLC |
005 |
20231117033240.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
081212s1992 caua ob 001 0 eng d |
040 |
|
|
|a E7B
|b eng
|e pn
|c E7B
|d OCLCQ
|d UBY
|d N$T
|d IDEBK
|d OCLCQ
|d OPELS
|d OCLCQ
|d OCLCF
|d OCLCO
|d OCLCQ
|d DEBSZ
|d LEAUB
|d VLY
|d INARC
|d OCLCO
|d COM
|d OCLCO
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 312746478
|a 505138290
|a 1162471054
|
020 |
|
|
|a 9780080583716
|q (electronic bk.)
|
020 |
|
|
|a 0080583717
|q (electronic bk.)
|
020 |
|
|
|a 012040527X
|q (electronic bk.)
|
020 |
|
|
|a 9780120405275
|q (electronic bk.)
|
020 |
|
|
|a 9786611739881
|
020 |
|
|
|a 6611739882
|
035 |
|
|
|a (OCoLC)646758023
|z (OCoLC)312746478
|z (OCoLC)505138290
|z (OCoLC)1162471054
|
050 |
|
4 |
|a RS402
|b .A6527 1992eb
|
072 |
|
7 |
|a MED
|x 023000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 072000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 058170
|2 bisacsh
|
082 |
0 |
4 |
|a 615./19
|2 22
|
245 |
0 |
0 |
|a Annual reports in medicinal chemistry.
|n Volume 27.
|
260 |
|
|
|a San Diego, Calif. ;
|a London :
|b Academic Press,
|c 1992.
|
300 |
|
|
|a 1 online resource (xi, 373 pages) :
|b illustrations.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
0 |
|
|a Annual reports in medicinal chemistry ;
|v v. 27
|
504 |
|
|
|a Includes bibliographical references and indexes.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Front Cover; Annual Reports in Medicinal Chemistry, Volume 27; Copyright Page; Contents; Contributors; Preface; SECTION I: CNS AGENTS; Chapter 1. The Decade of the Brain; Chapter 2. Pharmacological Intervention in Sleep and Circadian Processes; Chapter 3. Advances in Central Serotoninergics; Chapter 4. Traumatic and Ischemia/Reperfusion Injury to the CNS; Chapter 5. Trophic Factors and their Receptors in the CNS; Chapter 6. Antipsychotics; SECTION II: CARDIOVASCULAR AND PULMONARY AGENTS; Chapter 7. Angiotensin/Renin Modulators; Chapter 8. EDRF, an Emerging Target for Drug Design
|
505 |
8 |
|
|a Chapter 9. Endogenous Vasoactive PeptidesChapter 10. Recent Advances in Antiarrhythmic Therapy: Potassium Channel Antagonists; Chapter 11. Future Antithrombotic Therapy; Chapter 12. Pulmonary and Anti-Allergy Agents; SECTION III: CHEMOTHERAPEUTIC AGENTS; Chapter 13. Antibacterial Agents, Targets and Approaches; Chapter 14. Genetic Engineering of Antibiotic Producing Organisms; Chapter 15. Inhibitors of Angiogenesis; Chapter 16. Recent Advances in Antifungal Agents; Chapter 17. Progress in Antimicrobial Peptides; Chapter 18. Protein Tyrosine Kinases and Cancer
|
505 |
8 |
|
|a SECTION IV: IMMUNOLOGY, ENDOCRINOLOGY AND METABOLIC DISEASESChapter 19. Monoclonal Antibodies in Therapy; Chapter 20. Techniques for Determining Epitopes for Antibodies and T-cell Receptors; Chapter 21. Potential Therapeutic Modifers of the Complement Cascade; Chapter 22. Cytokine Modulation as a Medicinal Chemistry Target; Chapter 23. Recent Advances in the Discovery and Development of Potential Antidiabetic Agents; SECTION V: TOPICS IN BIOLOGY; Chapter 24. The Role of Homeobox Genes in Vertebrate Embryonic Development; Chapter 25. Emerging Therapies for Cystic Fibrosis
|
505 |
8 |
|
|a Chapter 26. The Guanylyl Cyclase Family of Receptor/EnzymesChapter 27. HIV Vaccine Development: From Empiricism to Medicinal Chemistry; Chapter 28. Inositol Triphosphate Receptors; SECTION VI: TOPICS IN DRUG DESIGN AND DISCOVERY; Chapter 29. Macromolecular X-Ray Crystallography and NMR as Tools for Structure-Based Drug Design; Chapter 30. Three-dimensional Models of G-Protein Coupled Receptors; Chapter 31. Carbohydrates as Drug Discovery Leads; Chapter 32. Sequence-Specific DNA Binding and the Regulation of Eukaryotic Gene Transcription; SECTION VII: TRENDS AND PERSPECTIVES
|
505 |
8 |
|
|a Chapter 33. To Market, To Market -- 1991COMPOUND NAME, CODE NUMBER AND SUBJECT INDEX, VOLUME 27; CUMULATIVE CHAPTER TITLES KEYWORD INDEX, VOLUMES 1-27; CUMULATIVE NCE INTRODUCTION INDEX, 1983-1991; CUMULATIVE NCE INTRODUCTION INDEX, 1983-1991, BY INDICATION
|
520 |
|
|
|a ANNUAL REPORTS IN MED CHEMISTRY V27 PPR.
|
546 |
|
|
|a English.
|
650 |
|
0 |
|a Pharmaceutical chemistry
|v Periodicals.
|
650 |
|
0 |
|a Clinical chemistry
|v Periodicals.
|
650 |
|
6 |
|a Chimie pharmaceutique
|0 (CaQQLa)201-0028674
|v P�eriodiques.
|0 (CaQQLa)201-0378307
|
650 |
|
6 |
|a Chimie clinique
|0 (CaQQLa)201-0016714
|v P�eriodiques.
|0 (CaQQLa)201-0378307
|
650 |
|
7 |
|a MEDICAL
|x Drug Guides.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Pharmacy.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Nursing
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Clinical chemistry
|2 fast
|0 (OCoLC)fst00864330
|
650 |
|
7 |
|a Pharmaceutical chemistry
|2 fast
|0 (OCoLC)fst01060115
|
655 |
|
2 |
|a Periodical
|0 (DNLM)D020492
|
655 |
|
7 |
|a periodicals.
|2 aat
|0 (CStmoGRI)aatgf300026657
|
655 |
|
7 |
|a Periodicals
|2 fast
|0 (OCoLC)fst01411641
|
655 |
|
7 |
|a Periodicals.
|2 lcgft
|
655 |
|
7 |
|a P�eriodiques.
|2 rvmgf
|0 (CaQQLa)RVMGF-000001105
|
700 |
1 |
|
|a Bristol, James A.,
|d 1946-
|
710 |
2 |
|
|a American Chemical Society.
|b Division of Medicinal Chemistry.
|
776 |
0 |
8 |
|i Print version:
|t Annual reports in medicinal chemistry. Volume 27.
|d San Diego : Academic Press, �1992
|z 9780120405275
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780120405275
|z Texto completo
|